Recruiting
Glioblastoma
RecruitingStudy on Glioblastoma Treatment with Olaptesed Pegol and Radiation, with Bevacizumab or Pembrolizumab, for Patients with Unmethylated MGMT Promoter
Registered drugNo placebo
Study on Glioblastoma Treatment with Olaptesed Pegol and Radiation, with Bevacizumab or Pembrolizumab, for Patients with Unmethylated MGMT Promoter
Registered drugNo placebo
- Disease:Glioblastoma
- Substances:BevacizumabOlaptesed Pegol+2
Countries:
Germany
Germany- Participants:18–64 years · 65+ years
- Substances:Bevacizumab
